Ex Parte Wong et al - Page 10



                Appeal No. 2004-0450                                                                           Page 10                    
                Application No. 09/785,936                                                                                                

                By definition, enzyme activity is the amount of an enzyme preparation required to effect                                  
                a defined amount of a specific reaction in a defined amount of time.”  (Id., page 10, first                               
                full paragraph).  The argument lacks merit.                                                                               
                        The ‘343 patent clearly and unequivocally discloses using Finase enzymes in an                                    
                aqueous suspension of a soy protein material; and it is undisputed on this record that                                    
                Finase is a commercially available enzyme preparation containing both phytase and                                         
                acid phosphatase.  The use of Finase is particularly preferred for the purposes of                                        
                carrying out the invention disclosed in the ‘343 patent, and its use is illustrated in                                    
                comparative examples 2 through 5, pages 7 through 10.  The reference puts a person                                        
                having ordinary skill in possession of the disclosed embodiment using Finase, and                                         
                applicants acknowledge that RNA would be degraded by using an enzyme preparation                                          
                containing acid phosphatase in the method of the ‘343 patent.  It appears reasonable to                                   
                say, therefore, that the amount of enzyme preparation used in the ‘343 patent is the                                      
                same or substantially the same as the amount recited in claim 79.  On these facts, the                                    
                burden of persuasion shifted to applicants to establish a difference between the amount                                   
                of enzyme preparation recited in claim 79 and the amount disclosed in the prior art                                       
                reference.  This applicants have not done.  Applicants have presented no objective                                        
                evidence or data on this record to show that the amount of enzyme used in the prior art                                   
                is distinguishable from the amount recited in claim 79.  In fact, applicants agree that                                   
                “RNA would be degraded by use of an enzyme preparation containing an acid                                                 
                phosphatase enzyme in the method of the ‘343 patent” (Appeal Brief, page 8, second                                        
                full paragraph).  Compare In re Best, 562 F.2d 1252, 1255, 195 USPQ 430, 433-434                                          






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007